Double test and Triple test are two very important tests during pregnancy to screen for fetal abnormalities. However, many pregnant mothers do not fully understand them. The following article will help mothers have a more detailed view of the similarities and differences between these two tests.

Double test prenatal screening test is used to screen for some genetic syndromes in the fetus. Knowing how to read the Double test results correctly will help parents better understand the health status of the fetus.

Turner syndrome is the most common sex chromosome disorder in women, causing a high rate of miscarriage, and the children born also have many incurable developmental disorders. To prevent the birth of children with Turner syndrome, high-risk pregnant women are advised to have prenatal screening tests.

Edward syndrome is a rare genetic disorder that affects babies. Children with Edward syndrome are unlikely to survive after birth and, if they are lucky enough to be born, will develop abnormally. It is the second most common syndrome, after Down syndrome, with a rate of 1/3,000 to 1/8,000 newborns affected.

Turner syndrome is the most common sex chromosome disorder in women, caused by a disorder of part or all of the X sex chromosome in the genome. The mechanism causing Turner syndrome is of interest to many scientists, clarifying it to effectively prevent this syndrome.

Patau syndrome is one of the chromosomal abnormalities encountered in the fetus, causing the baby to die in the womb or after the first year of life. NIPT screening helps detect Patau syndrome early.

Patau Syndrome - One of the most common genetic syndromes in fetuses, like other congenital malformation syndromes, Patau syndrome seriously affects the health of children from the time they are in the womb.

Prenatal screening is one of the important factors that helps pregnant women grasp the health status of the fetus and helps doctors make decisions about intervention before or after birth if the baby has abnormalities.

Measuring nuchal translucency is a necessary and very important task in monitoring the development of the fetus. Usually in the 11th-14th week of pregnancy, the pregnant mother will be instructed by the doctor to measure nuchal translucency. Based on the results of the nuchal translucency measurement, the doctor will make a diagnosis of the condition of the fetus. If the results are abnormal,

Prenatal diagnostic tests are tests that help doctors know for sure whether the fetus has genetic abnormalities and infections. Usually these tests are based on amniocentesis and chorionic villus sampling. After having the results of prenatal genetic diagnosis, parents can decide to terminate the pregnancy or consult a doctor.

Amniocentesis to test for fetal abnormalities is a procedure usually performed at weeks 15-18 of pregnancy. Amniocentesis helps detect early fetal abnormalities due to genetic abnormalities related to chromosomal disorders.